viernes, 23 de junio de 2023

FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs Agency Recommendations Aim to Inform Psychedelic Drug Development

https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario